61762 Federal Register / Vol. 75, No. 193 / Wednesday, October 6, 2010 / Notices 

DC 20201. Please refer all inquires to 

cfsac@hhs.gov. 

SUPPLEMENTARY INFORMATION: CFSAC 

was established on September 5, 2002. 

The Committee was established to 

advise, consult with, and make 

recommendations to the Secretary, 

through the Assistant Secretary for 

Health, on a broad range of topics 

including (1) the current state of 

knowledge and research about the 

epidemiology and risk factors relating to 

chronic fatigue syndrome, and 

identifying potential opportunities in 

these areas; (2) current and proposed 

diagnosis and treatment methods for 

chronic fatigue syndrome; and (3) 

development and implementation of 

programs to inform the public, health 

care professionals, and the biomedical, 

academic, and research communities 

about chronic fatigue syndrome 

advances. 

Since CFSAC was established, 

renewal of the Committee charter has 

been carried out at the appropriate 

intervals as stipulated by FACA. The 

previous Committee charter was 

scheduled to expire on September 5, 

2010. On August 19, 2010, the Secretary 

of Health and Human Services approved 

for the Committee charter to be 

renewed. The new charter was effected 

and filed with the appropriate 

congressional offices and Library of 

Congress on September 5, 2010. 

Renewal of the CFSAC charter provides 

authorization for the Committee to 

operate until September 5, 2012. 

A copy of the Committee charter is 

available on the CFSAC Web site at 

http://www.hhs.gov/advcomcfs. A copy 

of the Committee charter also can be 

obtained by accessing the FACA 

database that is maintained by the 

Committee Management Secretariat 

under the General Services 

Administration. The Web site address 

for the FACA database is http://fido.gov/ 

facadatabase. 

Dated: September 30, 2010. 

Wanda K. Jones, 

Designated Federal Officer, Chronic Fatigue 

Syndrome Advisory Committee. 

[FR Doc. 2010–25111 Filed 10–5–10; 8:45 am] 

BILLING CODE 4150–42–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–10–10HC] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 or send 

comments to Maryam Daneshvar, CDC 

Reports Clearance Officer, 1600 Clifton 

Road, MS–D74, Atlanta, GA 30333 or 

send an e-mail to omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

HIV/AIDS Awareness Day Programs— 

New—National Center for HIV/AIDS, 

Viral Hepatitis, STD, and Tuberculosis 

Prevention (NCHHSTP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

CDC is requesting OMB approval to 

administer surveys to respondents who 

plan HIV/AIDS day awareness activities 

during the next 3 years. The name and 

dates for the annual HIV/AIDS 

awareness day events are: National 

Black HIV Awareness Day—February 

7th; National Native HIV/AIDS 

Awareness Day—March 20th; National 

Asian and Pacific Islander HIV/AIDS 

Awareness Day—May 19th; and 

National Latino AIDS Awareness Day— 

October 15th. The purpose of the 

surveys is to assess the number and 

types of HIV/AIDS prevention activities 

planned and implemented in 

observance of each of the four noted 

HIV/AIDS awareness day events. 

After the date that each event occurs, 

the event planners will be asked to 

respond to a computer-based survey to 

collect qualitative data. Event planners 

will access the designated website to 

enter information about their particular 

event and identify the kind of events 

they planned. The survey results are 

necessary to understand how and where 

HIV/AIDS awareness activities are 

planned and implemented. 

These survey results will provide 

important information that will be used 

to develop HIV/AIDS prevention 

activities. The computer-based surveys 

take up to one hour. The surveys are a 

single activity and will not require a 

follow-up. There is no cost to the 

respondents other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

African-American HIV/AIDS awareness day activity planners.National Black HIV/AIDS Awareness 

Day Evaluation Report.

200 1 1 200 

Asian and Pacific Islander HIV/AIDS 

awareness day activity planners.

National Asian & Pacific Islander 

HIV/AIDS Awareness Day Evaluation Report.

15 1 1 15 

Latino HIV/AIDS awareness day activity planners.National Latino AIDS Awareness 

Day Evaluation Report.

125 1 1 125 

Native HIV/AIDS awareness day activity planners.National Native HIV/AIDS Awareness Day Evaluation Report.35 1 1 35 

Total ........................................... ........................................................... ........................ ........................ ........................ 375 

mstockstill on DSKH9S0YB1PROD with NOTICES

Federal Register / Vol. 75, No. 193 / Wednesday, October 6, 2010 / Notices 61763 

Dated: September 30, 2010. 

Carol Walker, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2010–25198 Filed 10–5–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission of OMB Review; Comment 

Request; Drug Accountability Record 

(Form NIH 2564) (NCI) 

SUMMARY: In compliance with the 

requirement of Section 3507(a)(1)(D) of 

the Paperwork Reduction Act of 1995, 

for opportunity for public comment on 

proposed data collection projects, the 

National Cancer Institute, the National 

Cancer Institute (NIH) has submitted to 

the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collected 

below. This proposed information 

collection was previously published in 

the Federal Register on August 4, 2010 

(75 FR 46945) and allowed 60 days for 

public comment. No public comments 

were received. The purpose of this 

notice is to allow an additional 30 days 

for public comment. The National 

Institutes of Health may not conduct or 

sponsor, and the respondent is not 

required to respond to, an information 

collection that has been extended, 

revised, or implemented on or after 

March 1, 2011, unless it displays a valid 

OMB control number. 

Proposed Collection: Title: Drug 

Accountability Record (NCI) (Form NIH 

2564) (OMB No.0925–0240). Type of 

Information Collection Request: 

Extension with changes. Need and Use 

of Information Collection: Food and 

Drug Administration (FDA) regulations 

require investigators to establish a 

record of the receipt, use and 

disposition of all investigational agents. 

The National Cancer Institute (NCI), as 

a sponsor of investigational drug trials, 

has the responsibility to assure the FDA 

that investigators in its clinical trials 

program are maintaining systems for 

drug accountability. In order to fulfill 

these requirements, a standard 

Investigational Drug Accountability 

Report Form (NIH 2564) was designed 

to account for drug inventories and 

usage by protocols. The data obtained 

from the drug accountability record will 

be used to keep track of the dispensing 

of investigational anticancer agents to 

patients. It is used by NCI management 

to ensure that investigational drug 

supplies are not diverted for 

inappropriate protocol or patient use. 

The information is also compared to 

patient flow sheets (protocol reporting 

forms) during site visits conducted for 

each investigator once every three years. 

All comparisons are done with the 

intention of ensuring protocol, patient 

and drug compliance for patient and 

drug compliance for patient safety and 

protections. Frequency of Response: 

Approximately 16 times per year. 

Affected Public: Private sector including 

businesses, other for-profit 

organizations, and non-profit 

institutions. Type of Respondents: 

Investigators, pharmacists, nurses, 

pharmacy technicians, and data 

managers. The annualized respondents’ 

burden is estimated to require 6,714 

hours (Table 1). There are no capital 

costs, operating costs, and maintenance 

cost to report. 

TABLE 1—ESTIMATES OF ANNUAL BURDEN HOURS

Type of respondents Number of 

respondents 

Frequency of 

response 

Average time 

per response 

Annnual 

burden 

hours 

Investigators, or Designees ............................................................................. 4,196 16 6/60 

(0.1) 

6,714 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies are invited 

on one or more of the following points: 

(1) Whether the proposed collection of 

information is necessary for the proper 

performance of the function of the 

agency, including whether the 

information will have practical utility; 

(2) The accuracy of the agency’s 

estimate of the burden of the proposed 

collection of information; including the 

validity of the methodology and 

assumptions used; (3) Ways to enhance 

the quality, utility and clarity of the 

information to be collected; and (4) 

Ways to minimize the burden of the 

collection of information on those who 

are to respond, including the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

Direct Comments to OMB: Written 

comments or suggestions regarding the 

item(s) contained in this notice, 

especially regarding the estimated 

public burden and associated response 

times, should be directed to the 

Attention: NIH Desk Officer, Office of 

Management and Budget, at 

OIRA_submission@omb.eop.gov or by 

fax to 202–395–6974. To request more 

information on the proposed project or 

to obtain a copy of the data collection 

plans and instruments, contact Charles 

L. Hall, Jr., Chief, Pharmaceutical 

Management Branch, Cancer Therapy 

Evaluation Program, Division of the 

Cancer Treatment and Diagnosis, and 

Centers, National Cancer Institute, 

Executive Plaza North, Room 7148, 9000 

Rockville Pike, Bethesda, MD 20892 or 

call non-toll-free number 301–496–5725 

or e-mail your request, including your 

address to: Hallch@mail.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 30 days following the 

date of this publication. 

Dated: September 27, 2010. 

Vivian Horovitch-Kelley, 

NCI Project Clearance Liaison, National 

Institutes of Health. 

[FR Doc. 2010–25190 Filed 10–5–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 

Comment Request; NCCAM Office of 

Communications and Public Liaison 

Communications Program Planning 

and Evaluation Research 

SUMMARY: Under the provisions of 

Section 3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Center for Complementary and 

Alternative Medicine (NCCAM), the 

National Institutes of Health (NIH), has 

submitted to the Office of Management 

and Budget (OMB) a request to review 

and approve the information collection 

mstockstill on DSKH9S0YB1PROD with NOTICES